[1] Baldari S, Di GR, Piccoli M, et al. Challenges and strategies for improving the regenerative effects of mesenchymal stromal cell-based therapies[J]. Int J Mol Sci, 2017, 18(10):2087. [2] Kim HJ, Park JS. Usage of human mesenchymal stem cells in cell-based therapy:advantages and disadvantages[J]. Dev Reprod, 2017, 21(1):1-10. [3] Afizah H, Hui JH. Mesenchymal stem cell therapy for osteoarthritis[J]. J Clin Orthop Trauma, 2016, 7(3):177-182. [4] de Windt TS, Vonk LA, Slaper-Cortenbach IC, et al. Allogeneic mesenchymal stem cells stimulate cartilage regeneration and are safe for single-stage cartilage repair in humans upon mixture with recycled autologous chondrons[J]. Stem Cells, 2017, 35(1):256-264. [5] Liu S, Liu D, Chen C, et al. MSC transplantation improves osteopenia via epigenetic regulation of notch signaling in lupus[J]. Cell Metab, 2015, 22(4):606-618. [6] Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells[J]. Science, 1999, 284(5411):143-147. [7] Turinetto V, Vitale E, Giachino C. Senescence in human mesenchymal stem cells:functional changes and implications in stem cell-based therapy[J]. Int J Mol Sci, 2016, 17(7):1164. [8] Wagner W, Horn P, Castoldi M, et al. Replicative senescence of mesenchymal stem cells:a continuous and organized process[J]. PLoS One, 2008, 3(5):e2213. [9] Kasper G, Mao L, Geissler S, et al. Insights into mesenchymal stem cell aging:involvement of antioxidant defense and actin cytoskeleton[J]. Stem Cells, 2009, 27(6):1288-1297. [10] Kretlow JD, Jin YQ, Liu W, et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells[J]. BMC Cell Biol, 2008, 9(1):60. [11] Kim S, Coulombe PA. Emerging role for the cytoskeleton as an organizer and regulator of translation[J]. Nat Rev Mol Cell Biol, 2010, 11(1):75-81. [12] Wada K, Itoga K, Okano T, et al. Hippo pathway regulation by cell morphology and stress fibers[J]. Development, 2011, 138(18):3907-3914. [13] Liu F, Lagares D, Choi KM, et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis[J]. Am J Physiol Lung Cell Mol Physiol, 2015, 308(4):L344-357. [14] Aragona M, Panciera T, Manfrin A, et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors[J]. Cell, 2013, 154(5):1047-1059. [15] Fernández BG, Gaspar P, Brás-Pereira C, et al. Actin-capping protein and the hippo pathway regulate F-actin and tissue growth in Drosophila[J]. Development, 2011, 138(11):2337-2346. [16] Baker N, Boyette LB, Tuan RS. Characterization of bone marrow-derived mesenchymal stem cells in aging[J]. Bone, 2015, 70:37-47. [17] Childs BG, Durik M, Baker DJ, et al. Cellular senescence in aging and age-related disease:from mechanisms to therapy[J]. Nat Med, 2015, 21(12):1424-1435. [18] Caliari SR, Vega SL, Kwon M, et al. Dimensionality and spreading influence MSC YAP/TAZ signaling in hydrogel environments[J]. Biomaterials, 2016, 103:314-323. [19] Xie Q, Chen J, Feng H, et al. YAP/TEAD-mediated transcription controls cellular senescence[J]. Cancer Res, 2013, 73(12):3615-3624. [20] Jin H, Lian N, Zhang F, et al. Inhibition of YAP signaling contributes to senescence of hepatic stellate cells induced by tetramethylpyrazine[J]. Eur J Pharm Sci, 2016, 96:323-333. [21] 刘源,王海萍,吕洋,等.不同浓度 Wnt-11 诱导骨髓间充质干细胞向心肌样细胞定向分化的实验研究[J].西安交通大学学报:医学版,2017,38(2):199-205. |